In collaboration with Institut Pasteur de Lille and the Center for Infection & Immunity of Lille (CIIL), Physiogenex now delivers its diet-induced obese NASH hamster as a unique metabolic comorbidities model infected with SARS-Cov-2, to accelerate the development...
Physiogenex is proud to partner with the Digital 4th Annual NASH Summit (Dec. 16-17, 2020). Our Director of Research and Business Development Dr. François Briand will be presenting our innovative NASH animal models on Dec. the 16th at 12:30 (EST) / 9:30 (PT) am. Don’t...
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.